Droperidol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Droperidol and local guidelines before prescribing.
Butyrophenone
Mechanism
Butyrophenone antiemetic and antipsychotic.
Uses
Postoperative nausea, acute agitation.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
QT prolongation, sedation, extrapyramidal effects.
Interactions
QT-prolonging drugs.
Contraindications and cautions
QT prolongation, Parkinson disease
Monitoring
ECG
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Caution in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
ECG monitoring; correct potassium and magnesium.
More from the textbook: uses, cautions and other points
- Droperidol , prochlorperazine, metoclopramide (dopamine antagonists — extrapyramidal effects; avoid in Parkinson's), aprepitant.
Anaesthesia: Airway management and anaesthetic drugs - Prevention — reduce baseline risk (TIVA with propofol, regional anaesthesia, minimise opioids, avoid nitrous oxide, adequate hydration); multimodal prophylaxis by risk — dexamethasone plus ondansetron (plus a third agent — droperidol, cyclizine, aprepitant — in high risk).
Anaesthesia: Perioperative care, pain and anaesthetic complications - Prophylaxis with dexamethasone and ondansetron , plus a third agent (e.g. droperidol or cyclizine).
Anaesthesia: Perioperative care, pain and anaesthetic complications - Antipsychotics - haloperidol, quetiapine, chlorpromazine, droperidol.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy